Sodium-glucose cotransporter 2 inhibition does not reduce hepatic steatosis in overweight, insulin-resistant patients without type 2 diabetes. (2020)
Attributed to:
Dissecting the steroid metabolome in the pathogenesis and treatment of metabolic liver disease
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/jgh3.12274
PubMed Identifier: 32514450
Publication URI: http://europepmc.org/abstract/MED/32514450
Type: Journal Article/Review
Volume: 4
Parent Publication: JGH open : an open access journal of gastroenterology and hepatology
Issue: 3
ISSN: 2397-9070